about
sameAs
The effect of refurbishing a UK steel plant on PM10 metal composition and ability to induce inflammation.Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calciumCombustion-derived nanoparticles: a review of their toxicology following inhalation exposureCarbon black nanoparticles induce type II epithelial cells to release chemotaxins for alveolar macrophages.Toxicological effect of engineered nanomaterials on the liverNanomaterials vs Ambient Ultrafine Particles: an Opportunity to Exchange Toxicology KnowledgeThe global variability of diatomaceous earth toxicity: a physicochemical and in vitro investigationOrgan burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposureEfficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammationPublic health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutantsIdentification of the mechanisms that drive the toxicity of TiO(2 )particulates: the contribution of physicochemical characteristicsComparative hazard identification by a single dose lung exposure of zinc oxide and silver nanomaterials in miceExpert consensus on an in vitro approach to assess pulmonary fibrogenic potential of aerosolized nanomaterials.Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue modelITS-NANO--prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy.The potential risks of nanomaterials: a review carried out for ECETOCCarbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot studySafe handling of nanotechnologySynthesis, characterization and evaluation of in vitro toxicity in hepatocytes of linear polyesters with varied aromatic and aliphatic co-monomers.Research priorities to advance eco-responsible nanotechnology.Intracellular imaging of nanoparticles: is it an elemental mistake to believe what you see?A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity.An in vitro assessment of panel of engineered nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, oxidative stress and genotoxicity.Oxidative stress and calcium signaling in the adverse effects of environmental particles (PM10).Accumulation dynamics and acute toxicity of silver nanoparticles to Daphnia magna and Lumbriculus variegatus: implications for metal modeling approaches.Current hypotheses on the mechanisms of toxicity of ultrafine particles.Athens 2004: the pollution climate and athletic performance.Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use.An in vitro liver model--assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials.Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.A Tractable Method for Measuring Nanomaterial Risk Using Bayesian Networks.Development of in vitro systems for nanotoxicology: methodological considerations.The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics.Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature.Review of carbon nanotubes toxicity and exposure--appraisal of human health risk assessment based on open literature.Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices.Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications.Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles.
P50
Q24811620-095C3DBF-71B2-41C0-8C0F-827B2120B5B8Q24815627-F989A32D-F1D3-4482-9D39-A5222582A3D2Q24815866-DA77FD83-D7D0-43FA-9A1A-8D901A026A60Q25255066-3783FB7B-2668-4A0E-9020-008B26329C5DQ27692098-4C3A679E-212D-461D-8082-2D96C844586FQ28073054-CB33C488-5C39-4884-9424-018669D2807DQ28384004-90222289-242D-4AC0-A8B6-12642D130B34Q28385901-A1A83908-BFE8-45A1-B551-065164DC0F70Q28387584-472537DC-130D-4BB0-BB2A-8319A3A7CAD4Q28387978-5765B480-B7A1-420B-B8C8-D21E5D0D5B55Q28393024-B16CE915-CBA1-4921-BA6A-473845063822Q28393869-0DD01FA7-3D51-4FA9-9FC8-B53961879C62Q28396160-CA9C6080-5810-493A-85DD-7D719DB56DD8Q28396392-B5415182-96A5-4187-BC2B-F677F493F6E2Q28396439-39331AB1-EC08-44C4-A1AD-72E9DAED9C1BQ28767397-0C0F9CCB-6D2E-4EDF-A58D-11089A283E66Q29547366-F414A71A-0068-414E-96AC-1D312584C610Q29617531-9C985740-0A68-4098-9BA0-3415106C2D64Q30313947-B7CC9916-0CE7-46C6-939F-186D637B5D60Q33858612-F4FC8DCE-FA46-47A0-B095-4266CEE6FE14Q33981219-A2849FC5-48C6-45FC-A74A-FF83B9F8A27EQ34096546-BB87F318-D4AD-4C5E-BD2F-2C14CB35EC89Q34686994-77B8CCEF-C2D1-49A2-B79D-487C936DFF78Q35131710-6880D464-DD4C-4651-B482-657C597CBCA5Q35574522-45EC4A95-8C74-4543-8772-06E853CF88FAQ35751395-234D0B55-54B4-4AC8-BE52-938A5DDE1501Q36071493-A2483791-3D07-432B-B975-D9DFE27439C7Q36163772-CA82291B-AD54-4C03-893B-3051CC8D52B6Q36536036-E8A6118E-C9EF-4CD6-9544-674728B9EEB7Q37064383-DAD69A5B-FA89-468A-924D-CAD97AF7AB9AQ37415890-95CF23A7-A16E-4FBD-BEC5-C4160AE0DC37Q37570536-93F02CB1-B400-4105-AB1A-ACED517187F2Q37630089-011B7804-0E57-407A-BCE0-9325FB11BAA2Q37783302-561D37F1-8332-4481-A8E6-9F967AE8A4CAQ37783718-8DAD1E25-57B2-419F-B414-B844022DD4BBQ37791170-89509771-079E-4C72-88F8-354DEA51D33BQ37854600-AA0C60D2-1B14-4E72-8828-E5AC619A7E71Q38039780-BBC1BA7F-C66A-4660-AF68-D3FEC2BF241AQ38057778-929D50E5-2C4C-42C9-A786-636C59926015Q38078983-B15AB79C-60AF-4D60-B228-E00E188E0D84
P50
description
hulumtuese
@sq
onderzoeker
@nl
toxicologist
@en
հետազոտող
@hy
name
Vicki Stone
@ast
Vicki Stone
@en
Vicki Stone
@es
Vicki Stone
@fr
Vicki Stone
@sl
type
label
Vicki Stone
@ast
Vicki Stone
@en
Vicki Stone
@es
Vicki Stone
@fr
Vicki Stone
@sl
prefLabel
Vicki Stone
@ast
Vicki Stone
@en
Vicki Stone
@es
Vicki Stone
@fr
Vicki Stone
@sl
P106
P1153
55672572800
7007109142
P21
P31
P496
0000-0001-8346-7471